Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

NCT05692180 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05692180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 5, 2023
Completion date
December 23, 2026
Enrollment
94 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

asthma